Allogene Therapeutics Inc
(ALLO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 158,136 | 280,379 | 135,897 | 175,126 | 160,990 |
| Marketable Securities | 682,886 | 619,271 | 357,026 | 355,407 | 340,254 |
| TOTAL | $854,058 | $909,577 | $504,414 | $544,576 | $509,757 |
| Non-Current Assets | |||||
| PPE Net | 102,653 | 84,605 | 66,349 | 56,449 | 45,943 |
| Investments And Advances | 212,509 | 215,471 | 64,950 | 63,214 | 100,702 |
| Intangibles | 0 | 0 | 0 | 151 | 301 |
| Other Non-Current Assets | 53,280 | 48,891 | 52,810 | 53,412 | 38,841 |
| TOTAL | $368,442 | $348,967 | $184,109 | $173,226 | $185,787 |
| Total Assets | $1,222,500 | $1,258,544 | $688,523 | $717,802 | $695,544 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,151 | 9,057 | 7,199 | 9,250 | 8,047 |
| Accrued Expenses | 39,979 | 31,838 | 19,619 | 23,829 | 25,307 |
| TOTAL | $50,130 | $40,895 | $26,818 | $33,079 | $33,354 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 53,639 | 54,230 | 55,186 | 55,700 | 42,474 |
| TOTAL | $53,639 | $54,230 | $55,186 | $55,700 | $42,474 |
| Total Liabilities | $103,769 | $95,125 | $82,004 | $88,779 | $75,828 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 140,280 | 139,292 | 125,332 | 124,907 | 121,902 |
| Common Shares | 140 | 139 | 125 | 124 | 122 |
| Retained earnings | -577,773 | -511,576 | -450,602 | -396,122 | -335,092 |
| Other shareholders' equity | 953 | 1,830 | 1,610 | 1,145 | 1,866 |
| TOTAL | $1,118,731 | $1,163,419 | $606,519 | $629,023 | $619,716 |
| Total Liabilities And Equity | $1,222,500 | $1,258,544 | $688,523 | $717,802 | $695,544 |